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ABSTRACT 
Chromium-amino acid conjugates were isolated from systems initially containing 
either potassium dichromate and amino acid or chromic nitrate and amino acid. The 
elicitating properties of these chromium-amino acid conjugates were evaluated by 
intradermal injection of guinea pigs sensitized to chromium . Positive results were 
obtained with several conjugates . The conjugates prepared from chromic nitrate and amino 
acid were stronger elicitors than those prepared from potassium dichromate and amino acid. 
Landsteiner [1, 2] proposed the concept that 
allergy to simple chemicals involved conjugation 
of the simple chemical with a protein carrier, 
forming the complete antigen . This was confirmed 
by later workers. Eisen and co-workers [3-5] 
reported on the chemical reactions of the conjuga-
tion of dinitrobenzene residues to protein and the 
elicitation of allergic reactions with the resulting 
conjugates . Benacerraf and Gell [6, 7) reported on 
reactions to picryl conjugates in guinea pigs. Gell 
and Silverstein [8] demonstrated a carrier speci-
ficity in the formation of antigens. Cohen [9 1 
reported that human serum albumin acts as a 
carrier, while human gamma globulin participates 
to a much lesser extent (if at all) in chromium 
sensitivity. In a subsequent paper, Cohen [10] 
proposed that mucopolysaccharides also function 
as carriers of chromium in the manifestation of 
the allergic response mechanism. Based on studies 
in our laboratories+, we would agree that serum 
albumin-chromium conjugates may be elicitors, 
but we cannot confirm the role attributed to the 
m ucopolysacc h arides. 
Berrens [11) proposed that amino acid-hapten 
conjugates have an important function as inter-
mediate messengers in the process of sensitiza-
tion. Jansen and co-workers [12, 131 demonstrated 
that a nickel-alanine complex can elicit reactions 
in sensitized animals. There are, however, no re-
ports of the eliciting properties of chromium-
amino acid conjugates in chromium-sensitive 
subjects . Consequently, we undertook the prep-
aration of chromium-amino acid conjugates and 
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an evaluation of their eliciting properties in 
guinea pigs sensitized to chromium. 
MATEHIALS AND MP.THOD>i 
Chromium-amino acid conjugates were prepared as 
follows: Approximately 1 millimole of the desired amino 
acid was dissolved in 3 ml of 0.1 N hydrochloric acid. 
One-ml aliquots of the amino acid solutions were treated 
with either 1 ml of 1.0 x 10- 3 M chromic nitrate solu-
tion to produce complexes with trivalent chromium or 
1 ml of 1.0 x 10- 3 M potassium dichromate solution 
to produce complexes with hexavalent chromium. 
Control solutions were prepared by mixing 1 ml of 
the amino acid solutions with an equal volume of dis-
tilled water and carrying them through the remainder 
of the procedures. In addition 1-ml samples of 0.1 N 
hydrochloric acid were treated with 1 ml of either 1.0 
x 10-• M chromic nitrate or 1.0 x 10- 3 M potassium 
dichromate and carried through the procedure as con-
trols. A distilled-water control was treated similarly. 
The amino acid-chromium mixtures and the controls 
were allowed to stand at room temperature for five days . 
After that time, each solution was neutralized to litmus 
with 0.1 M TRIS (trishydroxymethylaminomethane) 
and batch extracted with two 1-gm portions ofDowex-50 . 
·to remove uncomplexed cationic trivalent chromium . 
The solutions were each treated with 1 ml of dilute 
hydrochloric acid and batch extracted with two 1-ml 
portions of MIBK (4-methylpentanone, 2) to remove 
excess hexavalent chromium. Each solution was evapo-
rated to dryness under vacuum . The solid residues were 
taken up in 1 ml of physiologic saline solution, filtered, 
and sterilized by passage through Millipore filters . 
Conjugates of chromium with alanine (ALA), arginine 
(ARG), aspartic acid (ASP), cystine (CYS), glycine 
(GLY), histidine (HIS), leucine (LEU), lysine (LYS), 
methionine (MET), norvaline (NOR), ornithine (ORN), 
phenylalanine (PHE), proline (PRO), serine (SER), 
tryptophan (TRY), and tryosine (TYR) were prepared in 
the above manner. The chemical properties of these 
conjugates will be the subject of a future report. 
Two sets of guinea pigs were used . One set was 
sensitized to potassium dichromate by the technique of 
Gross et al [14]. (Albino guinea pigs weighing 300 to 500 
gm were sensitized to hexavalent chromium by three 
subcutaneous injections in the nape one week apart. The 
following emulsion was injected: 0.5 ml Freund 's com-
plete adjuvant [Difco] with 0.5 ml of 3.4 x 10-' M 
k,Cr,O,). The second set was not sensitized; it served as 
a control group in the detection of the irritant effects of 
the materials used. The eliciting properties of the 
chromium conjugates were evaluated by intradermal 
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injections of 0.1 ml of each conjugate and each control in 
the two sets of guinea pigs. The eliciting doses contained 
1 x 10-• millimole of chromium-amino acid conjugate 
(corresponding to 0.025 to 0.045 mg depending on the 
amino acid) or 3 x w-• millimoles of uncomplexed 
amino acid (corresponding to 3 to 7 mg of amino acid 
again depending on the amino acid). 
RESULTS 
Results of skin tests are summarized in the 
Table. 
The following chromium-amino acid conjugates 
were elicitors in chromium-sensitized guinea pigs: 
alanine-Cr (III), alanine-Cr (VI), arginine-Cr 
TABLE I 
Results of skin tests with hexavalent and trivalent chromium-amino acid conjugates in sensitized and control guinea 
pigs 
Challenge Reactions in sensitized animals Reactions in control animals 
material A ·s c D E F AVG. G H I J AVG. 
ALA 0 0 0 0 0 0 0.0 0 0 0 0 0.0 
ALA-Cr(III) +3 +2 +2 +2 +1 +2 2.0 0 0 0 0 0.0 
ALA-Cr(Vl) +2 ± +2 +2 +1 +2 1.6 +1 0 0 0 0.3 
ARG 0 0 0 0 0 0 0.0 0 0 0 0 0.0 
ARG-Cr(IIO +1 +1 +1 +2 ± + 2 1.2 0 0 0 0 0.0 
ARG-Cr(VI) ± 0 0 +1 ± +1 0.5 0 0 0 0 0.0 
ASP +1P +1P +1P +1P +2P +1P l.lP ± ± + 1 0 0.4 
ASP-Cr(III) +1P +2P +2P ±P + 2P + 2P 1.6P ± +1 +1 0 0.6 
ASP-Cr(VI) ± +2 +1P ±P + 1P +2P l.lP +1 +1 + 2 0 1.0 
CYS +1 ± ± ± ± +1 0.7 0 0 ± 0 0.1 
CYS-Cr(III) + 2 +1 +1 +1 ± +2 1.3 0 ± ± 0 0.3 
CYS-Cr(VI) +2 +1 +2 +1 ± +3 1.6 ± 0 0 0 0.1 
GLY 0 •• 0 c± 0 0 0.1 0 0 •• •• 0.0 
GL Y -Cr(III) 0 •• 0 +1 +2 0 0.6 0 0 .. •• 0.0 
GLY-Cr(Vl) ± •• ± -t-2 +1 +1 1.0 0 +1 •• •• 0.5 
HIS +1 •• +1 ± +2 +1 1.1 ± ± •• •• 0.5 
HIS-Cr(III) + 3 •• +2 +2 +2 +1 2.0 +1 + 1 •• •• 1.0 
HIS-Cr(Vl) +2 •• +1 +2 +2 +1 1.6 ± + 1 •• .. 0.8 
LEU 0 0 0 0 0 0 0.0 0 0 0 0 0.0 
LEU-Cr(III) +1 + 1 +2 0 0 + 1 0.8 0 0 +1 0 0.3 
LEU-Cr(VI) ± 0 +2 0 0 +1 0.6 0 0 ± 0 0.1 
LYS ± •• ± 0 ± ± 0.4 0 0 •• .. 0.0 
L YS-Cr(IIJ) +2 •• ± 0 +2 +2 1.3 0 +1 .. •• 0.5 
LYS-Cr(VI) +1 •• +1 +1 0 + 1 0.8 0 0 •• •• 0.0 
MET 0 0 0 0 0 0 0.0 0 0 0 0 0.0 
MET-Cr(IIO +1 + 1 + 2 0 +1 +1 1.0 0 0 0 0 0.0 
MET-Cr(Vl) +1 ± +1 0 ± +1 0.7 0 0 0 0 0.0 
NOR + 1 •• +1 0 0 +1 0.6 0 0 •• •• 0.0 
NOR-Cr(III) +2 •• +1 +1 +2 +2 1.6 0 +1 •• •• 0.5 
NOR-Cr(VI) + 1 •• +1 0 0 + 1 0.6 +1 + 1 .. •• 1.0 
ORN +1P •• +1 0 +1P •• 0.8P +LP 0 .. •• 0.5P 
ORN-Cr(III) +2 •• +2 +2 + 3 •• 2.3 +1 +2 •• •• 1.5 
ORN-Cr(Vl) + 1 .. +2 +1 + 1 .. 1.2 +1 +1 •• ** 1.0 
PHE ± ± ± 0 0 0 0.3 0 0 0 0 0.0 
PHE-Cr(III) +1 +1 + 2 +1 +1 +1 1.1 0 0 +1 0 0.3 
PHE-Cr(VI) + 1 +1 + 1 +1 0 + 1 0.9 0 0 ± 0 0.1 
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TABLE !-Continued 
Challenge Reactions in sensitized animals Reactions in con trot animals 
material A B 
PRO 0 •• 
PRO-Cr(III) +4 •• 
PRO-Cr(Vl) +3 •• 
SER 0 0 
SER-Cr(Ill) 0 +1 
SER-Cr(Vl) +1 +2 
TRY ± •• 
TRY -Cr(III) +3 •• 
TRY-Cr(Vl) +2 •• 
TYR 0 0 
TYR-Cr(IIl) +1 +1 
TYR-Cr(VI) +2 +1 
4.2 X w-·M K,Cr,07 +3 •• 
4.2 X w-· M CrCl, +1 •• 
Distilled Water 0 ** 
P =Pustule 
* • = animal died 
Skin tests were evaluated as follows: 
0 no response 
± equivocal results 
+ 1 response of 10 mm diameter 
+2 response of 15 mm diameter 
+3 response of 20 mm diameter 
c D E 
0 ± 0 
+4 +3 +4 
+2 +1 +2 
0 0 0 
0 0 0 
+1 0 0 
± 0 ± 
+3 +3 +4 
+2 +2 +2 
0 0 0 
+1 0 0 
+2 0 0 
+4 +3 +4 
0 +1 +1 
0 0 0 
F AVG. G H I J AVG. 
± 0.2 0 0 •• •• 0.0 
+4 3.8 +1 +3 •• •• 2.0 
+3 2.2 ± +1 •• •• 0.8 
0 0.0 0 0 +1 0 0.3 
0 0.2 0 0 0 0 0.0 
0 0.7 +1 +1 +1 0 0.8 
0 0.3 0 0 •• •• 0.0 
+3 3.2 +2 ± •• •• 1.3 
+2 2.0 0 ± •• •• 0.3 
0 0.0 0 0 0 0 0.0 
0 0.5 0 0 0 0 0.0 
0 0.8 +1 0 +1 0 0.5 
+3 3.4 0 0 •• •• 0.0 
+2 1.0 0 0 •• ** 0.0 
0 0.0 0 0 ** •• 0.0 
+4 response of 20 mm diameter with central necrosis 
(III), cystine-Cr (III), cystine-Cr (VI), methio-
nine-Cr (III), phenylalanine-Cr (III), proline-Cr 
(III), proline-Cr (VI), tryptophan-Cr (III), trypto-
phan-Cr (VI). The remaining conjugates tested 
produced either low reactions (less than 1 +) or 
were irritating in the control animals. 
DlSCl'SSIO!\ 
Although the guinea pigs were sensitized with 
hexavalent chromium and responded more 
strongly to challenge with unconjugated hexava-
lent chromium than with unconjugated trivalent 
chromium, the amino acid-chromium (III) conju-
gates consistently produced more pronounced 
reactions than the amino acid-chromium (VI) 
conjugates. We interpret this as a further indica-
tion that chemical reduction of hexavalent chrom-
imp precedes conjugatioq. At this time, we are 
unable to define the mechanism of this reduction, 
nor can we define the exact role played by the 
amino acids themselves. We have previously 
demonstrated [15] that the sulfur-containing 
amino acids are able to chemically reduce hexava-
lent chromium and that trivalent chromiun forms 
complexes with several amino acids. Conjugation 
pf ~hromium (III) with these amino acids appar-
entiy yields a product of three to five times greater 
antigenicity than unconjugated chromium (III). 
By the same token, conjugation with hexavalent 
chromium decreased antigenicity. 
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